CD36, insulin resistance, and coronary heart disease.
Aitman
T J
TJ
Molecular Medicine Group, MRC Clinical Sciences Center Imperial College Genetics and Genomics Research Institute, Hammersmith Hospital, London, UK. t.aitman@csc.mrc.ac.uk
D000818:Animals; D018955:CD36 Antigens / Q000235:genetics / Q000502:physiology*; D003327:Coronary Disease / Q000235:genetics / Q000503:physiopathology*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D009154:Mutation; D009687:Nuclear Proteins / Q000502:physiology; D027361:Organic Anion Transporters; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D015398:Signal Transduction; D014157:Transcription Factors / Q000502:physiology
D018955:CD36 Antigens; D008562:Membrane Glycoproteins; D009687:Nuclear Proteins; D027361:Organic Anion Transporters; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors